93% of cancer patients respond to souped-up-immune cells

9EB2DCC2-C47B-4B16-8AE1-F3AC34FAAE75

In a new study of CAR T-cell therapy for cancer, 93% of patients responded to the treatment.

 Two physicians had major roles in a cutting-edge clinical trial using the body’s own immune cells to fight late-stage cancer, one as a researcher and one as a patient.

Senior author Patrick Reagan, an assistant professor of hematology/oncology at University of Rochester Medicine’s Wilmot Cancer Institute, helped run the national clinical investigation of CAR T-cell therapy.

Continue reading… “93% of cancer patients respond to souped-up-immune cells”

0